People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Other Energy, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Catalyze Holdings, LLC | — | Other Energy | Series A | $4.6M | $48.8M | 2019 |
| Origin Endoscopy Inc. | — | Biotechnology | Seed | $2.3M | $10.0M | 2024 |
Michael Freeman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Freeman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Geshwiler | 1 | 5 |
| Jeremy Starkweather | 1 | 4 |
| Jason Grimes | 1 | 3 |
| Steve Atherton | 1 | 2 |
| Jason Ylizarde | 1 | 2 |
| John Wynne | 1 | 2 |
| Kim Driscoll | 1 | 1 |
| Tim Rebhorn | 1 | 1 |
| Joel Serface | 1 | 1 |
| Stephen Hoag | 1 | 1 |
| Shawn Cumberland | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.